A combination of wild polio cases and people who contracted the disease as a result of being vaccinated has led to a backlash against the World Health Organization-led immunization program in Nigeria. As a result, the number of new cases of polio has almost doubled this year.
The news is the unfortunate follow-on from the admission by the WHO that, since 2005, 71 children were infected in Nigeria and Niger with polio as a result of taking an oral vaccine against the disease (Marketletter October 15, 2007). Conspiracy theories were already being circulated by suspicious religious leaders, who described the vaccine as intended to "sterilize Islamic children" or to infect them with HIV/AIDS. The reluctant and late admission by the WHO and the US Centers for Disease Control and Prevention (CDC) of problems with the drug appear to have exacerbated the situation.
Compared with last year, when there were 54 cases of wild polio virus, 2008 has seen 106 people affected. A report by the Associated Press stated that eight children this year alone have been infected with vaccine-triggered polio. The AP added that an injected-vaccine could be used which does not have the same adverse event rate as the oral treatment, but this has been rejected on grounds of cost and infrastructure requirements: a physician or a nurse would be needed to administer the therapy's delivery.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze